Featured Article
Boston Scientific, a global medical technology company, had a strongly positive Q1 2024. Revenue rose 14% to $3.9 billion and earnings before interest and taxes rose 22 % to $674 million over the same period last year. A review of Boston Scientific’s 24 April earnings call and associated financial reports provided insight regarding the importance of pricing on performance. Pricing was not mentioned in their earnings call. Margins were briefly mentioned by…
Read MoreIn This Issue
Since we have entered the time for prognostication, I offer these visions of the digital future. We all know the e-tech bubble…
Read More Recent news concerning power outages have been of dour amusement for this Chicagoan. Once again, a subset of people (read: the state)…
Read More
Is Enron coming for lunch? Introduction The past three decades have offered ample evidence of the ability of disruptive technologies to create…
Read More
Economic transactions and industrial reorganizations are akin to the evolution of a complex system punctuated with periods of equilibrium and non-equilibrium dynamics.…
Read More